BioHealth News Archive
NOT-OD-13-109: NIH Offers Niche Assessment Program to SBIR and STTR Phase
NIH announces the availability of a Niche Assessment Program for its SBIR/STTR Phase I awardees funded in fiscal years (FY) 2013 and 2014. All…
Read MoreMontgomery County Rocks the Inc. 500 List
Ten of Maryland's nineteen fastest-growing companies are located in Montgomery County – including the state's highest-ranking company and two of our incubator companies! Ten…
Read MoreUMB Pharmacy Researchers Develop Promising Chronic Pain Drug
A team of researchers led by Andrew Coop, PhD, professor and chair of the Department of Pharmaceutical Sciences (PSC) at the University of Maryland…
Read MoreLeggett, Montgomery business and civic leaders to visit China – The Washington Post
Montgomery County Executive Isiah Leggett will visit China next month, leading a delegation of business and civic leaders looking for partnership opportunities in areas…
Read MoreBD ProbeTec™ Trichomonas vaginalis Qx Assay Launches on the BD Viper™ System with XTR™ Technology in the United States
BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the U.S. Food and…
Read MoreFirst tenants relocate to Highlandtown tech incubator – The Baltimore Guide
One of the first tenants to lease at Emerging Technology Center’s new Highlandtown location is SameGrain, developer of a social discovery platform that helps people anonymously…
Read MoreATCC Announces Creation of Biomaterial Contributor Network
ATCC, the premier global biological materials resource and standards organization, announces material deposit agreements with over 30 leading public and private institutions. These institutions…
Read MoreJohns Hopkins Researchers Find Promising Therapeutic Target for Hard-To-Treat Brain Tumor
Johns Hopkins researchers say they have found a specific protein in nearly 100 percent of high-grade meningiomas — the most common form of brain…
Read MoreAstraZeneca to buy US cancer firm for up to $500 million
AstraZeneca Plc took a further step to bolster its pipeline of new cancer drugs on Monday by agreeing to acquire privately held U.S. biotech…
Read MoreA healthcare innovator’s guide to must-know tech terms for the next decade of medicine
Electronic medical records. DNA sequencing. Big data. These technology trends are changing the way medicine is practiced today — but what's coming next? I…
Read MoreCyber Security & Healthcare Investment Conference – September 11, 2013
Forum Agenda: 7:30 a.m. - 5 p.m. Jones Day Terrace & Conference Center 51 Louisiana Ave, NW | Washington, D.C. With the increasing adoption…
Read MoreNovartis holds annual healthcare entrepreneur competition to generate insight into healthcare and innovation of tomorrow – MarketWatch
Novartis International AG / Novartis holds annual healthcare entrepreneur competition to generate insight into healthcare and innovation of tomorrow . Processed and transmitted by…
Read MoreReal-Time MRI Helps Neurosurgeons During Surgeries | MIT Technology Review
A new system for visualizing the brain during surgery is helping neurosurgeons more accurately diagnose and treat patients and is even allowing them to…
Read MoreHoward County plots incubator for socially conscious startups – Baltimore Business Journal
Howard County has plans for a new incubator that would aim to develop companies with a socially conscious focus. The Conscious Venture Lab is…
Read MoreMedImmune strengthens immune-mediated cancer therapy portfolio with acquisition of Amplimmune
AstraZeneca today announced that MedImmune, its global biologics research and development arm, has entered into a definitive agreement to acquire Amplimmune, a privately-held, Maryland,…
Read More